Clinical Trial

Evaluating a Liquid Extract of Carob to Improve Blood Sugar in People With Prediabetes

Study acronym: GLIA
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated February 2, 2026 (before its estimated April 15, 2026 completion). Its status may not reflect the trial's current state.
Summary
This study evaluates whether a liquid carob extract can improve blood glucose levels in individuals with prediabetes. Participants are selected according to predefined health criteria and randomly assigned to two groups: one group receives the carob extract and the other receives an inert liquid (placebo). Blood samples are collected and glucose-related parameters are measured throughout the study to assess changes over time. The objective is to determine whether this extract may contribute to better glycemic control and help prevent progression to diabetes.
Trial Details
NCT Number NCT07379931
Lead Sponsor Universidad Católica San Antonio de Murcia
Conditions Prediabetes (Insulin Resistance, Impaired Glucose Tolerance)
Enrollment 70 participants
Start Date 2026-01-01
Primary Completion 2026-04-15 (estimated)
Study Completion 2026-04-30 (estimated)
Updated on ClinicalTrials.gov 2026-02-02